Healthcare Sector

DXCM

Market Tracker

$77.76
-2.33
(-2.91%)
12:00 pm
Next Earnings: (est.) 07/27/23 12:00 am
  • DXCM (Selected)

    DexCom, Inc.

DXCM Support / Resistance Levels

Loading Data..
WhaleStream

15m Chart - Support and Resistance levels are based on the large dark pool & equity prints at the plotted levels. Displays strongest levels above and below the spot price.

DXCM Most Active Options Strike Prices Whale BUY Activity - 5 day

Loading Data..

Represents the strikes that had the highest premium of whale flow (on the ASK side) over the past 5 trading days.

DXCM Most Active Options Strike Prices Whale SALES Activity - 5 day

Loading Data..

Represents the strikes that had the highest premium of whale flow (on the BID side) over the past 5 trading days.

DXCM Dark Pool and Public Equity Key Price Levels

Loading Data..

Represents the largest cumulative premium levels above and below the current spot price. The price in the pink bubble represents the spot price.

DXCM Open Interest Trend

Loading Data..

Total Open Interest of Calls & Puts across all strikes and expirations over the past 16 trading days.

DXCM Largest 1-Day Open Interest Movements

Expires Type Strike OI Change Percent
01/17/2025 CALL $97.50 3,258 +1,049 +47.49%
01/17/2025 CALL $88.00 4,371 +931 +27.06%
01/17/2025 CALL $90.00 2,135 +728 +51.74%
06/20/2025 CALL $100.00 1,186 +74 +6.65%
01/17/2025 CALL $84.00 204 +70 +52.24%
01/17/2025 PUT $73.00 81 +43 +113.16%
01/10/2025 CALL $81.00 458 -16 -3.38%
03/21/2025 PUT $95.00 102 -19 -15.70%
01/10/2025 PUT $78.00 100 -27 -21.26%
06/20/2025 CALL $80.00 1,477 -34 -2.25%
01/17/2025 CALL $85.00 8,236 -251 -2.96%
01/17/2025 CALL $80.00 11,006 -266 -2.36%

Contracts with largest changes in open interest from the previous trading day to the current/most recent.

DXCM Major Holders

Name Pct Held Shares Total
Vanguard Total Stock Market Index Fund 3.03% 11.75M 1.57B
Vanguard Mid-Cap Index Fund 2.32% 8.99M 1.2B
Vanguard 500 Index Fund 2.30% 8.93M 1.19B
Invesco ETF Tr-Invesco QQQ Tr, Series 1 ETF 1.31% 5.08M 679.14M
Fidelity 500 Index Fund 1.09% 4.23M 566.01M
SPDR S&P 500 ETF Trust 1.08% 4.17M 558.06M
College Retirement Equities Fund-Growth Account 0.89% 3.46M 461.99M
iShares Core S&P 500 ETF 0.89% 3.45M 460.81M
Growth Fund Of America Inc 0.87% 3.36M 449.71M
Vanguard Growth Index Fund 0.84% 3.26M 435.8M

DXCM News

  • 3 Beaten-Down Stocks That May Be Due for Big Comebacks in 2025

    01/08 09:30 am

    The Motley Fool

    Read more
  • Rethinking Diabetes Care: PatentVest Pulse Unveils Key Insights on the Expanding CGM Market and the Innovations Driving Change

    01/07 11:00 am

    GlobeNewswire Inc.

    Read more
  • These Were the 5 Worst-Performing Stocks in the Nasdaq-100 in 2024

    01/04 08:45 am

    The Motley Fool

    Read more
  • 1 Reason to Sell DexCom Stock, and 1 Reason to Buy

    12/21 07:45 am

    The Motley Fool

    Read more
  • 3 Reasons to Buy DexCom Stock Like There's No Tomorrow

    12/02 10:12 am

    The Motley Fool

    Read more
  • 2 Excellent Healthcare Stocks to Hold Through the Next Decade

    11/28 08:45 am

    The Motley Fool

    Read more
  • These Are the 5 Worst-Performing Stocks in the Nasdaq-100 With 2024 Almost Over

    11/26 08:30 am

    The Motley Fool

    Read more
  • Wearable Patch Market to Expand at a High 7.9% CAGR through 2031 | SkyQuest Technology

    11/25 06:10 am

    Benzinga

    Read more
  • 2 Superior Growth Stocks to Buy Right Now If You have $1,000 to Invest

    11/24 11:15 am

    The Motley Fool

    Read more
  • 1 Stock to Buy Near Its 52-Week Low and Hold for 10 Years

    11/08 11:15 am

    The Motley Fool

    Read more
  • Tive Announces Inaugural Winners of the Green Impact Award: Celebrating Environmental Stewardship in Supply Chain Management

    10/29 09:00 am

    GlobeNewswire Inc.

    Read more
  • Connected Healthcare Devices Market to hit USD 240 billion by 2032, says Global Market Insights Inc.

    10/28 06:38 am

    GlobeNewswire Inc.

    Read more
  • Why DexCom Stock Flopped on Friday

    10/25 05:53 pm

    The Motley Fool

    Read more
  • DXCM DEADLINE: RLF, A LEADING LAW FIRM, Encourages DexCom, Inc. Investors With Losses in Excess of $100K to Secure Counsel Before Important October 21 Deadline in Securities Class Action – DXCM

    10/20 05:54 pm

    GlobeNewswire Inc.

    Read more
  • Where Will DexCom Be in 5 Years?

    10/18 08:00 am

    The Motley Fool

    Read more
  • SHAREHOLDER ALERT: Holzer & Holzer, LLC Reminds Investors of the October 21, 2024 Lead Plaintiff Deadline in Class Action Lawsuits Filed on Behalf of DexCom, Inc. (DXCM), Orthofix Medical Inc. (OFIX), and Spire Global, Inc. (SPIR) Shareholders

    10/17 05:18 pm

    GlobeNewswire Inc.

    Read more
  • Is Abbott Laboratories Stock a Buy?

    10/17 07:30 am

    The Motley Fool

    Read more
  • Glancy Prongay & Murray LLP Reminds Investors of Looming Deadline in the Class Action Lawsuit Against DexCom, Inc. (DXCM)

    10/16 12:00 pm

    GlobeNewswire Inc.

    Read more
  • ROSEN, LEADING TRIAL ATTORNEYS, Encourages DexCom, Inc. Investors to Secure Counsel Before Important October 21 Deadline in Securities Class Action – DXCM

    10/13 12:05 pm

    GlobeNewswire Inc.

    Read more
  • DXCM SHAREHOLDER ALERT: A Securities Fraud Lawsuit was Filed against DexCom, Inc.; Investors are Urged to Contact BFA Law before October 21 Court Deadline (Nasdaq:DXCM)

    10/13 07:33 am

    GlobeNewswire Inc.

    Read more
  • 2 Magnificent Stocks to Buy That Are Near 52-Week Lows

    10/12 11:40 am

    The Motley Fool

    Read more
  • DexCom, Inc. (DXCM) Investors: October 21, 2024 Filing Deadline in Securities Class Action - Contact Kessler Topaz Meltzer & Check, LLP

    10/12 11:15 am

    GlobeNewswire Inc.

    Read more
  • SHAREHOLDER ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of DexCom

    10/11 11:53 am

    GlobeNewswire Inc.

    Read more
  • ROSEN, LEADING INVESTOR COUNSEL, Encourages DexCom, Inc. Investors to Secure Counsel Before Important October 21 Deadline in Securities Class Action – DXCM

    10/10 08:36 pm

    GlobeNewswire Inc.

    Read more
  • DXCM FRAUD NEWS: October 21 Class Action Deadline is Approaching; DexCom, Inc. Investors that Lost Money are Notified to Contact BFA Law (Nasdaq:DXCM)

    10/09 06:47 am

    GlobeNewswire Inc.

    Read more
  • DEXCOM, INC. (NASDAQ: DXCM) DEADLINE ALERT: Bernstein Liebhard LLP Reminds DexCom, Inc. Investors of Upcoming Deadline

    10/07 03:01 pm

    GlobeNewswire Inc.

    Read more
  • ROSEN, A TRUSTED AND LEADING LAW FIRM, Encourages DexCom, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – DXCM

    10/06 06:34 am

    GlobeNewswire Inc.

    Read more
  • 2 Beaten-Down Growth Stocks You Might Regret Not Buying

    10/05 06:45 am

    The Motley Fool

    Read more
  • DXCM LITIGATION ALERT: DexCom, Inc. Investors are Notified to Contact BFA Law before Imminent October 21 Deadline in Securities Fraud Class Action (Nasdaq:DXCM)

    10/05 06:43 am

    GlobeNewswire Inc.

    Read more
  • Is DexCom a Millionaire Maker?

    10/05 05:43 am

    The Motley Fool

    Read more
  • DXCM Deadline Approaching on October 21, 2024: Kessler Topaz Meltzer & Check, LLP Reminds DexCom, Inc. (DXCM) Investors of Class Action Lawsuit Deadline

    10/04 09:31 am

    GlobeNewswire Inc.

    Read more
  • ROSEN, A HIGHLY RECOGNIZED LAW FIRM, Encourages DexCom, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – DXCM

    10/03 08:50 pm

    GlobeNewswire Inc.

    Read more
  • DXCM INVESTOR NOTICE: Robbins Geller Rudman & Dowd LLP Announces that DexCom, Inc. Investors with Substantial Losses Have Opportunity to Lead Case

    10/03 05:40 pm

    GlobeNewswire Inc.

    Read more
  • Down More Than 50%, Is DexCom Stock a Bargain Now?

    10/02 04:11 am

    The Motley Fool

    Read more
  • ROSEN, NATIONAL TRIAL LAWYERS, Encourages DexCom, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – DXCM

    09/30 06:48 pm

    GlobeNewswire Inc.

    Read more
  • DexCom (DXCM) Accused of Misleading Investors About Sales Force Changes and Financial Outlook- Hagens Berman

    09/30 03:29 pm

    GlobeNewswire Inc.

    Read more
  • Global Chronic Disease Management Market Size to Reach USD 17.28 Billion by 2033 | Witnessing a CAGR of 12.80%

    09/30 02:40 pm

    GlobeNewswire Inc.

    Read more
  • 2 Magnificent Growth Stocks Down 45% and 32% to Buy Right Now

    09/30 07:15 am

    The Motley Fool

    Read more
  • DXCM STOCK UPDATE: Investors of DexCom, Inc. are Alerted of Imminent October 21 Deadline; Contact BFA Law if You Lost Money (Nasdaq:DXCM)

    09/29 06:31 am

    GlobeNewswire Inc.

    Read more
  • DexCom, Stellantis, Symbotic, and NANO Nuclear Energy Class Action Update: Johnson Fistel Alerts Shareholders of Ongoing Class Action Proceedings

    09/27 10:48 am

    GlobeNewswire Inc.

    Read more
  • DXCM ANNOUNCEMENT: Kessler Topaz Meltzer & Check, LLP Notifies Investors of a Class Action Lawsuit Against DexCom, Inc.

    09/26 08:32 pm

    GlobeNewswire Inc.

    Read more
  • Kirby McInerney LLP Notifies Investors of Lead Plaintiff Deadline in Dexcom Inc. (DXCM) Securities Class Action

    09/26 04:28 pm

    GlobeNewswire Inc.

    Read more
  • SHAREHOLDER ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of DexCom

    09/25 08:42 pm

    GlobeNewswire Inc.

    Read more
  • DexCom Is Great. Here's Why You Shouldn't Buy It.

    09/25 09:45 am

    The Motley Fool

    Read more
  • Is DexCom a Millionaire Maker?

    09/25 08:07 am

    The Motley Fool

    Read more
  • ROSEN, A RANKED AND LEADING FIRM, Encourages DexCom, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – DXCM

    09/24 08:03 pm

    GlobeNewswire Inc.

    Read more
  • Glancy Prongay & Murray LLP Reminds Investors of Looming Deadline in the Class Action Lawsuit Against DexCom, Inc. (DXCM)

    09/24 01:43 pm

    GlobeNewswire Inc.

    Read more
  • DexCom (DXCM) Blamed Disruptive Sales Force Changes For Its Disappointing Q2 2024 Results And Outlook, Resulting In 40% Stock Drop And Class Action - Hagens Berman

    09/23 03:51 pm

    GlobeNewswire Inc.

    Read more
  • ROSEN, A RANKED AND LEADING FIRM, Encourages DexCom, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – DXCM

    09/21 09:30 am

    GlobeNewswire Inc.

    Read more
👀

Follow the Whales in real-time.

🎁

Take 50% OFF With Code: